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Abstract
AIM
To investigate the feasibility and safety of secondary 
endoscopic submucosal dissection (ESD) for residual or 
locally recurrent gastric tumors. 
METHODS
Between 2010 and 2017, 1623 consecutive patients 
underwent ESD for gastric neoplasms at a single tertiary 
referral center. Among these, 28 patients underwent 
secondary ESD for a residual or locally recurrent 
tumor. Our analysis compared clinicopathologic factors 
between primary ESD and secondary ESD groups. 
RESULTS
The en bloc resection and curative rate of resection of 
secondary ESD were 92.9% and 89.3%, respectively. 
The average procedure time of secondary ESD was 
significantly longer than primary ESD (78.2 min vs  
55.1 min, P  = 0.004), and the adverse events rate was 
not significantly different but trended slightly higher 
in the secondary ESD group compared to the primary 
ESD group (10.7% vs  3.8%, P  = 0.095). Patients 
who received secondary ESD had favorable outcomes 
without severe adverse events. During a mean follow-
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up period, no local recurrence occurred in patients who 
received secondary ESD. 
CONCLUSION
Secondary ESD of residual or locally recurrent gastric 
tumors appears to be a feasible and curative treatment 
though it requires greater technical efficiency and longer 
procedure time.
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Core tip: Although secondary endoscopic submucosal 
dissection (ESD) is technically demanding, it can be 
applied to residual or recurrent tumors. We categorized 
secondary ESD into three groups according to the 
surgical strategy and analyzed them. There is no 
consensus on the timing of salvage ESD. This is the first 
study to report the feasibility and safety of secondary 
ESD according to the timing of ESD. Although secondary 
ESD requires greater technical efficiency and a longer 
procedure time, secondary ESD of residual or locally 
recurrent gastric tumors appears to be a feasible and 
curative treatment.
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INTRODUCTION
Endoscopic submucosal dissection (ESD) technique has 
evolved, and various lesions can now be treated with 
ESD, regardless of their size and site, including ulcer scars 
with severe fibrosis[1,2]. To achieve curative resection, 
it is very important to accurately predict the margin of 
neoplasm before ESD. Therefore, chromoendoscopy, 
magnifying endoscopy, and magnifying image-enhanced 
endoscopy are widely used to determine the appropriate 
lesion margin[3,4]. However, despite these efforts, the 
positive lateral margins of a neoplasm can still occur after 
ESD. According to the Japanese gastric cancer treatment 
guidelines, surgical resection should be performed after 
non-curative resection of early gastric cancer[5]. However, 
for patients with differentiated carcinoma in which the 
positive lateral margin is the only non-curative factor, 
secondary ESD can be performed given the low risk of 
lymph node metastasis in such cases.
Primary ESD is a relatively established technique 
that dissects along the loose submucosal layer. However, 
secondary ESD is difficult because the submucosal layer 
is eliminated by the previous endoscopic resection and 
is replaced with fibrosis. In patients who have positive 
lateral margin after primary ESD, early secondary ESD 
is performed within a few days. This can be technically 
difficult because the orientation of the residual lesion 
might be confusing and development of submucosal 
fibrosis may have begun[6]. Late secondary ESD is 
performed a few months after the primary ESD and is 
also technically demanding because of severe submucosal 
fibrosis. Until recently, there have only been a few 
reports of secondary ESD for residual or locally recurrent 
tumors[6-8]. Therefore, this study aimed to investigate the 
feasibility and safety of secondary ESD procedures for 
residual or locally recurrent gastric neoplasms.
MATERIALS AND METHODS
Patients
Between January 2010 and February 2017, 1623 
consecutive patients underwent gastric ESD for gastric 
neoplasms at Gangnam Severance Hospital in Seoul, 
Korea. Among these, 28 patients received secondary 
ESD for residual or locally recurrent tumors. We com-
pared clinicopathologic factors between secondary ESD 
(28 patients) and primary ESD (1595 patients). The 
prospectively collected database of ESD and medical 
records were then reviewed and analyzed retrospectively 
to determine the feasibility and safety of ESD for residual 
or locally recurrent tumors. The Institutional Review 
Board (IRB) of Gangnam Severance Hospitals approved 
this study.
ESD procedure
Procedures were primarily performed using one or two 
ESD knives, including a DualKnife (Olympus Co., Tokyo, 
Japan), FlexKnife (Olympus Co., Tokyo, Japan), HookKnife 
(Olympus Co., Tokyo, Japan), and/or an insulated-tip knife 
(Olympus Co., Tokyo, Japan). Following circumferential 
marking (via argon plasma coagulation), a mixture of 
indigo carmine, epinephrine, and 10% glycerol (Cerol; 
JW Pharmaceutical Co, Seoul, South Korea) was used 
to inject the submucosa. The mucosa surrounding each 
lesion was then incised and dissection of the submucosal 
layer ensued. Hemostasis during ESD and ablation of 
visible vessels at the post-ESD ulcer site were achieved 
using hemostatic forceps (Coagrasper; Olympus Co, 
Tokyo, Japan). For the electrosurgical unit, the VIO300D 
(ERBE, Tuebingen, Germany) was used. Mucosal incision 
was performed using the Endocut I current (effect 2, cut 
duration 4, interval 3), and submucosal dissection was 
carried out with the swift coagulation current (effect 3, 
40 W). The visible vessels were ablated using the soft 
coagulation current (effect 3, 60 W).
Secondary ESD procedure
In this study, secondary ESD refers to an additional 
ESD procedure for residual or locally recurrent tumors. 
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Early salvage ESD was performed immediately after 
histological confirmation of positive lateral margins of 
the initial ESD specimen (Figure 1). Late salvage ESD 
was prescribed when the positive lateral margin was 
histologically confirmed after the initial ESD, and was 
performed after complete healing of the artificial ulcer 
caused by the initial ESD (Figure 2). Late secondary 
ESD was performed when local recurrence was proven 
histologically during the follow-up period after initially 
curative primary ESD (Figure 3). The general sequence 
of early or late salvage and late secondary ESD were 
similar to that of the primary ESD. However, sodium 
hyaluronate (LG Life Science Co., Seoul, South Korea) 
was frequently used as a submucosal injection material 
to overcome non-lifting signs induced by ulceration and 
fibrosis of the submucosal layer caused by the primary 
ESD[9]. In general, a non-insulated knife was used for 
dissecting fibrotic areas that were not lifted due to 
fibrosis. Additionally, to achieve an appropriate angle 
for a dissecting view of the submucosa in fibrotic area, 
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Figure 1  Case of early salvage endoscopic submucosal dissection. A 52 year old female patient was diagnosed with a 6 cm early gastric cancer on the posterior 
wall of the lower body. The primary ESD procedure was performed, and en bloc resection was achieved. The pathology report indicated the positive lateral margin. 
Early salvage ESD was performed after histological confirmation of positive lateral margins of the initial ESD specimen. ESD: Endoscopic submucosal dissection.
Figure 2  Case of late salvage endoscopic submucosal dissection. A 52 year old male patient was diagnosed with a 3 cm early gastric cancer on the posterior 
wall of the lower body. The primary ESD procedure was performed, and piecemeal resection was done incompletely due to severe bleeding and adhesion. Late 
salvage ESD was performed after complete healing of the artificial ulcer caused by the primary ESD. ESD: Endoscopic submucosal dissection.
Jung DH et al . Secondary ESD for gastric neoplasms
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ESD and 28 patients underwent secondary ESD. Six 
of these patients (21.4%) and eight of these patients 
(28.6%) underwent early and late salvage ESD for 
residual lesions, respectively, while fourteen of these 
patients (50.0%) underwent late secondary ESD for 
locally recurrent lesions. Baseline characteristics of the 
gastric lesions treated by ESD are shown in Table 1. 
There were significantly more depressed macroscopic 
lesions in the secondary ESD group and there were no 
significant differences in lesion location or size between 
the two groups. We investigated the initial lesion 
corresponding to secondary ESD. The initial lesions 
corresponding to secondary ESD were dysplasia in 13 
patients, and carcinoma in 15 patients. A total of 15 
patients with carcinoma had mucosal cancer without 
lymphovascular invasion.
Procedure outcomes
When we compared the procedure outcomes of the 1595 
patients in the primary ESD group and the 28 patients 
in the secondary ESD group, the resected specimen size 
in the secondary ESD group was significantly larger than 
that of the primary ESD group, though the lesion size of 
two groups was not different. Next, significant differences 
in procedure outcomes were identified by comparing 
the primary ESD group and the secondary ESD group 
(Table 2). Patients in the secondary ESD group had a 
longer mean ESD procedure time than patients in the 
primary ESD group (78.2 min vs 55.1 min, P = 0.004). 
Additionally, the dissection times for the secondary 
ESD group were significantly longer than that of the 
primary ESD group (63.4 min vs 36.7 min, P < 0.001). 
Furthermore, the dissection speed was significantly lower 
in the secondary ESD group than in the primary ESD 
the submucosal dissection was initiated in a non-fibrotic 
area of sufficient distance from the fibrotic area. 
Histopathological evaluation of tumors
En bloc resection was defined as a tumor that was 
removed whole as a single piece. Curative resection 
was defined as expanded indications according to the 
Japanese gastric cancer treatment guidelines[5]. According 
to the Japanese gastric cancer treatment guidelines, the 
expanded indications for curative endoscopic resection 
(ER) were en bloc resection, negative lateral and vertical 
margins, no lymphovascular invasion (LVI) and one 
of the following: (1) Tumor size > 2 cm, differentiated 
type, mucosa, and ulcer (-); (2) tumor size ≤ 3 cm, 
differentiated type, mucosa, and ulcer (+); (3) tumor 
size ≤ 2 cm, undifferentiated type, mucosa, and ulcer 
(-); or (4) tumor size ≤ 3 cm, differentiated type, and 
submucosa1 (SM1, < 500 μm from the muscularis 
mucosa).
Statistical analysis 
Comparison of clinicopathologic factors between primary 
ESD and secondary ESD was performed using the chi-
square test and Fisher’s exact test. The Student’s t-test 
was used for intergroup comparison of non-categorical 
variables. The accepted significance level was a P value 
< 0.05. All statistical analyses were performed using the 
software SPSS version 12.0 for Windows (SPSS Inc., 
Chicago, IL, United States).
RESULTS
Demographic and clinicopathologic characteristics
Among 1623 patients, 1595 patients received primary 
Figure 3  Case of late secondary endoscopic submucosal dissection. A 61 year old male patient was diagnosed with a 1.7 cm high grade dysplasia on the lesser 
curvature of the angle. The primary ESD procedure was performed, and en bloc resection was achieved. The local recurrence was shown five years after initial 
curative primary ESD. Late secondary ESD was performed. ESD: Endoscopic submucosal dissection.
Jung DH et al . Secondary ESD for gastric neoplasms
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Table 1  Baseline characteristics
Characteristics ESD Secondary ESD P value
(n  = 1595, %) (n  = 28, %)
Gender 0. 836
   Male 1117 (70.0) 19 (67.9)
   Female 478 (30.0) 9 (32.1)
Age [yr, mean (SD)] 64.8 (10.4) 63.5 (9.2) 0.528
Lesion location 0.217
   Upper 127 (8.0) 3 (11.1)
   Middle 633 (39.7) 15 (53.6)
   Lower 835 (52.4) 10 (35.7)
Multiplicity 250 (15.7) 2 (7.1) 0.296
Lesion size [mm, mean (SD)] 17.4 (12.8) 16.4 (13.2) 0.664
Macroscopic type < 0.001
   Elevated 674 (42.3) 7 (25.0)
   Flat 685 (42.9) 9 (32.1)
   Depressed 236 (14.8) 12 (42.9)
WHO classification < 0.001
   Low grade dysplasia 610 (38.2) 8 (28.6)
   High grade dysplasia 221 (13.9) 4 (14.3)
   Well differentiated 356 (22.3) 4 (14.3)
   Moderately differentiated 268 (16.8) 7 (25.0)
   Poorly differentiated 76 (4.8) 3 (10.7)
   Signet ring cell carcinoma 64 (4.0) 0 (0.0)
   No residual lesion 0 (0.0) 2 (7.1)
Depth of invasion < 0.001
   Dysplasia 831 (52.1) 12 (42.9)
   Mucosal cancer 609 (38.2) 14 (50.0)
   Submucosal cancer 155 (9.7) 0 (0.0)
   No residual lesion 0 (0.0) 2 (7.1)
LVI 1.000
   No 1546 (96.9) 28 (100.0)
   Yes 49 (3.1) 0 (0.0)
Lateral margin 0.381
   Negative 1521 (95.4) 26 (92.9)
   Positive 74 (4.6) 2 (7.1)
Vertical margin 0.615
   Negative 1542 (96.7) 27 (96.4)
   Positive 53 (3.3) 1 (3.6)
ESD: Endoscopic submucosal dissection; LVI: Lymphovascular invasion.
Table 2  Comparison of procedural outcomes and oncologic outcomes between the primary endoscopic submucosal dissection group 
and secondary endoscopic submucosal dissection group 
ESD Secondary ESD P value
(n  = 1595, %) (n  = 28, %)
Lesion size [mm, mean (SD)] 17.4 (12.8) 16.4 (13.2) 0.664
Specimen size [mm, mean (SD)] 38.1 (14.6) 47.8 (19.6) 0.001
Whole procedure time [min, mean (SD)] 55.1 (41.5) 78.2 (38.0) 0.004
Dissection time [min, mean (SD)] 36.7 (34.7) 63.4 (38.0) < 0.001
Dissection speed [mm2/min, mean (SD)] 38.7 (32.8) 22.1 (12.7) < 0.001
Complication 61 (3.8) 3 (10.7) 0.095
   Perforation 37 (2.3) 0 (0.0)
   Bleeding 15 (0.9) 1 (3.6)
   Aspiration pneumonia 13 (0.8) 2 (7.1)
Hospital stay [d, mean (SD)] 3.6 (3.2) 3.9 (2.5) 0.639
En bloc resection 1574 (98.7) 26 (92.9) 0.058
Curative resection 1383 (86.7) 25 (89.3) 1.000
Additive salvage treatment 104 (6.5) 3 (10.7) 0.425
   Additive surgery 85 (5.3) 2 (7.1)
   Redo ESD 16 (1.0) 1 (3.6)
   Argon plasma coagulation 3 (0.2) 0 (0.0)
ESD: Endoscopic submucosal dissection.
Jung DH et al . Secondary ESD for gastric neoplasms
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group (22.1 mm2/min vs 38.7 mm2/min, P < 0.001). 
The adverse events rate in the secondary ESD group was 
not significantly different but trended slightly higher than 
that in the primary ESD group (10.7% vs 3.8%, P = 
0.095). There were no perforations in the secondary ESD 
group.
Oncologic outcomes 
The en bloc resection and curative rates of resection of 
secondary ESD were 92.9% and 89.3%, respectively. 
These rates were comparable with those of primary 
ESD, which had an en bloc resection rate of 98.7% 
and a curative resection rate of 86.7% (Table 2). Three 
patients in the secondary ESD group had additive 
salvage treatments due to a positive lateral margin (n 
= 2) and other synchronous lesions that had vertical 
margin involvement after secondary ESD (n = 1). One 
patient in the secondary ESD group showed a positive 
vertical margin with a very focal extension of dysplasia. 
This patient was 75 years old and decided to be observed 
and was followed up closely. During follow-up, one 
patient who received secondary ESD presented with 
metachronous recurrence 25 months after secondary 
ESD. We evaluated the outcomes according to an 
institutional learning curve based upon the initial phase 
and the late phase of the study period. The en bloc 
resection rate was not significantly different (initial phase 
vs late phase, 98.4% vs 98.8%, P = 0.533). Curative 
resection rate was significantly lower in initial phase vs 
late phase (84.6% vs 88.8%, P = 0.013). When we 
evaluated the outcomes in the secondary ESD group, the 
en bloc and curative resection rates were not statistically 
different (initial phase vs late phase, 100% vs 88.2%, P 
= 0.505 and 90.9 % vs 88.2%, P = 1.000, respectively). 
Subgroup analysis according to surgical strategy
We categorized secondary ESD into three groups 
according to the surgical strategy (early salvage, late 
salvage, or late secondary ESD) (Table 3). The median 
interval times from the primary ESD to the secondary 
Table 3  Clinicopathologic characteristics according to surgical strategy
Characteristics Early salvage ESD (n  = 6, %) Late salvage ESD (n  = 8, %) Late secondary ESD (n  = 14, %) P  value
Gender 0. 909
   Male 4 (66.7) 5 (62.5) 10 (71.4)
   Female 2 (33.3) 3 (37.5) 4 (28.6)
Age [yr, mean (SD)] 65.4 (10.8) 61.6 (7.3) 63.8 (9.9) 0.749
Lesion location 0.255
   Upper 2 (33.3) 0 (0.0) 1 (7.1)
   Middle 2 (33.3) 4 (50.0) 9 (64.3)
   Lower 2 (33.3) 4 (50.0) 4 (28.6)
Multiplicity 0 (0.0) 1 (12.5) 1 (7.1) 0.668
Lesion size [mm, mean (SD)] 19.8 (22.4) 13.6 (10.9) 16.4 (9.8) 0.701
Initial method 0.341
   EMR 0 (0.0) 0 (0.0) 2 (14.3)
   ESD 6 (100.0) 8 (100.0) 12 (85.7)
Macroscopic type 0.014
   Elevated 0 (0.0) 0 (0.0) 7 (50.0)
   Flat 4 (66.7) 2 (25.0) 3 (21.4)
   Depressed 2 (33.3) 6 (75.0) 4 (28.6)
WHO classification 0.081
   Low grade dysplasia 2 (33.3) 3 (37.5) 3 (21.4)
   High grade dysplasia 0 (0.0) 1 (12.5) 3 (21.4)
   Well differentiated 1 (16.7) 0 (0.0) 3 (21.4)
   Moderately differentiated 1 (16.7) 4 (50.0) 2 (14.3)
   Poorly differentiated 0 (0.0) 0 (0.0) 3 (21.4)
   Signet ring cell carcinoma 0 (0.0) 0 (0.0) 0 (0.0)
   No residual lesion 2 (33.3) 0 (0.0) 0 (0.0)
Depth of invasion 0.090
   Dysplasia 2 (33.3) 4 (50.0) 6 (42.9)
   Mucosal cancer 2 (33.3) 4 (50.0) 8 (57.1)
   Submucosal cancer 0 (0.0) 0 (0.0) 0 (0.0)
   No residual lesion 2 (33.3) 0 (0.0) 0 (0.0)
LVI 1.000
   No 6 (100.0) 8 (100.0) 14 (100.0)
   Yes 0 (0.0) 0 (0.0) 0 (0.0)
Lateral margin 0.341
   Negative 6 (100.0) 8 (100.0) 12 (85.7)
   Positive 0 (0.0) 0 (0.0) 2 (14.3)
Vertical margin 0.617
   Negative 6 (100.0) 8 (100.0) 13 (92.9)
   Positive 0 (0.0) 0 (0.0) 1 (7.1)
EMR: Endoscopic mucosal resection; ESD: Endoscopic submucosal dissection; LVI: Lymphovascular invasion.
Jung DH et al . Secondary ESD for gastric neoplasms
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ESD were 6.5, 129.0, and 712.8 d in patients who 
received early salvage, late salvage, or late secondary 
ESD, respectively. Hospital stay was significantly longer 
in early salvage ESD group compared with late salvage 
and late secondary ESD groups (7.2 d vs 3.0 d and 3.0 
d, P ≤ 0.001). There was no other significant difference 
in procedure outcomes among the three groups (Table 
4). The en bloc and curative resection rates of early and 
late salvage groups were both 100%. However, the en 
bloc and curative resection rates of the late secondary 
ESD group tended to be lower than that of the other 
groups (Table 4). 
DISCUSSION
ESD is now widely performed for gastric neoplasms 
and has favorable outcomes. However, the incomplete 
resection rate of ESD is 2.2% to 26.3%[10-21] and the 
local recurrence rate after ESD is 0% to 3%[15,16,22-24]. 
Therefore, the management of residual or locally 
recurrent gastric neoplasms after ESD continues to 
be problematic. Secondary ESD for a locally recurrent 
tumor is difficult to perform due to severe fibrosis and 
ulcer scar formation, and there are few published reports 
about secondary ESD for residual or locally recurrent 
gastric neoplasms. Bae et al[6] reported a total of 16 early 
secondary ESD cases in which the curative resection 
rate was 93.8% (15/16). Therefore, they asserted that 
early secondary ESD was a feasible and useful treatment 
in patients with a positive lateral margin. Additionally, 
secondary ESD was also determined to be an effective 
treatment for locally recurrent lesions after endoscopic 
mucosal resection (EMR)[7]. Oka et al[7] reported that 
the complete resection rate of ESD for a residual or 
locally recurrent lesion is 93.3% (14/15). Therefore, 
they suggested that secondary ESD was an effective and 
minimally invasive procedure for patients with residual or 
local recurrent tumors after EMR.
Secondary ESD is technically difficult due to the 
severe fibrosis and scar formation that results from 
primary ESD[25]. In this study, the mean procedure 
time and dissection time of secondary ESD was longer 
than that for primary ESD. In addition, the dissection 
speed was lower in the secondary ESD group than 
in the primary ESD group, while the adverse events 
rate of secondary ESD was slightly higher than that of 
primary ESD. That is, secondary ESD is associated with 
a greater technical difficulty, longer procedure time, 
and increased incidence of adverse events. However, 
in this study, bleeding after secondary ESD was 
managed endoscopically, without the need for further 
emergent operation; aspiration pneumonia was treated 
with antibiotics and conservative care. The aspiration 
pneumonia occurred in 15 (0.9%) patients. The procedure 
time was longer in patients with aspiration pneumonia 
than others (83.3 min vs 55.1 min, P = 0.125). However, 
the difference was not statistically significant. Although 
many endoscopists worry that submucosal fibrosis 
might cause perforation, in this study, there were no 
perforations reported in the secondary ESD group. We 
suspected that deep excavation by benign peptic ulcers 
would not preserve the muscle layer. However, the 
artificial ulcer caused by ESD was contracted, preserving 
the muscle layer, which was thicker than before ESD. 
Therefore, this observation may explain the rarity of 
perforation. Primary ESD procedures in this study were 
performed by one of five ESD endoscopists. Two of them 
were fully skilled experts (YYH, far more than a thousand 
cases of ESD experience; KJH, more than five hundreds 
cases of ESD experience) and the other three were less-
Table 4  Comparison of procedural outcomes and oncologic outcomes according to surgical strategy
Early salvage ESD (n  = 6, %) Late salvage ESD (n  = 8, %) Late secondary ESD (n  = 14, %) P  value
Lesion size [mm, mean (SD)] 19.8 (22.4) 13.6 (10.9) 16.4 (9.8) 0.701
Specimen size [mm, mean (SD)] 63.0 (33.0) 46.4 (11.6) 42.1 (12.8) 0.084
Whole procedure time [min, 
mean (SD)]
81.7 (48.5) 85.9 (24.3) 72.3 (41.1) 0.714
Dissection time [min, mean (SD)] 73.2 (46.8) 73.0 (23.4) 53.8 (40.7) 0.421
Dissection speed [mm2/min, 
mean (SD)]
19.4 (6.8) 19.0 (7.5) 24.9 (12.7) 0.512
Method 0.341
   ESD only 6 (100.0) 8 (100.0) 12 (85.7)
   ESD plus snaring 0 (0.0) 0 (0.0) 2 (14.3)
Complication 0 (0.0) 1 (12.5) 2 (14.3) 0.627
   Perforation 0 (0.0) 0 (0.0) 0 (0.0)
   Bleeding 0 (0.0) 0 (0.0) 1 (7.1)
   Aspiration pneumonia 0 (0.0) 1 (12.5) 1 (7.1)
Hospital stay [d, mean (SD)] 7.2 (2.9) 3.0 (1.8) 3.0 (1.2) < 0.001
Median interval [d, mean (SD)] 6.5 (3.1) 129.0 (133.6) 712.8 (546.5) 0.001
En bloc resection 6 (100.0) 8 (100.0) 12 (85.7) 0.341
Curative resection 6 (100.0) 8 (100.0) 11 (78.6) 0.186
Additive treatment 0 (0.0) 0 (0.0) 3 (21.4) 0.186
   Additive surgery 0 (0.0) 0 (0.0) 2 (14.3)
   Redo ESD 0 (0.0) 0 (0.0) 1 (7.1)
ESD: Endoscopic submucosal dissection.
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skilled ESD endoscopists whose ESD experience were 
less than a hundred cases. However, secondary ESD in 
this study was exclusively performed only by the two 
fully skilled ESD experts (YYH and KJH). That might be 
a reason why the outcomes of the secondary ESD group 
were relatively good despite the technical difficulty. 
ESD has multiple advantages compared to other 
treatment options for residual or locally recurrent 
tumors, such as gastrectomy and additional endoscopic 
treatment. Compared to gastrectomy, ESD offers 
improved quality of life, decreased morbidity, longer 
length of recovery, and lower healthcare costs. It also 
has advantages over other endoscopic treatments, such 
as argon plasma coagulation, including a high chance of 
en bloc resection, which allows for complete histologic 
assessment. Therefore, the application of secondary ESD 
for residual or locally recurrent tumors is an important 
treatment consideration. 
When we categorized secondary ESD according to 
the time interval from primary ESD, the main difference 
between early secondary ESD and late secondary ESD 
was scar formation. Early secondary ESD is performed 
while the ESD ulcer is still open, therefore, there is 
minimal fibrosis. However, by the time late secondary 
ESD is performed, the ulcer has healed with severe 
fibrosis[26]. In this study, we compared three groups: 
early salvage ESD, late salvage ESD, and late secondary 
ESD, and hospital stay of the early salvage ESD group 
was the longest. This difference was due to many 
patients in the early salvage ESD group that underwent 
primary and secondary ESD successively during a single 
hospitalization. There was no other significant difference 
in procedure outcomes regarding the whole procedure 
time, dissection time, and dissection speed among the 
three groups. Although the late salvage ESD and late 
secondary ESD groups had severe fibrosis and scar 
formations, no perforations occurred. 
According to this study, secondary ESD for residual 
or locally recurrent tumors is a safe, minimally invasive, 
and effective treatment. However, secondary ESD should 
be performed by an experienced endoscopist with 
precautions, including the appropriate electrosurgical 
knife, the appropriate dissection depth, and the careful 
gradual dissection of the severe fibrotic tissue along 
the plane of the deep submucosa or superficial proper 
muscle. Furthermore, the surrounding non-fibrotic 
tissue should first be dissected sufficiently to make a 
flap of the specimen and directly visualize the plane 
of the submucosa from the non-lifting fibrotic area to 
the fibrotic area[27,28]. Therefore, in this study, we found 
that the specimen size of the secondary ESD group 
was significantly larger than the primary ESD group. In 
addition, one recommendation for dissecting the fibrotic 
area is to dissect deeply along the surface of the muscle 
fiber because the ESD ulcer scar has an intact muscle 
layer. 
Correct diagnosis of the depth of invasion of 
residual or locally recurrent tumors is often difficult 
due to scar formation after ESD. Therefore, residual or 
locally recurrent tumors with submucosal invasion are 
sometimes misdiagnosed as mucosal cancer[29]. In this 
study, the depth of invasion of all secondary ESD was 
within the mucosa.
In previous reports, the curative resection rate for 
residual gastric neoplasms was 92% to 100%[6,26,30] 
and curative resection rate for locally recurrent gastric 
neoplasms was 76% (35/46) to 87% (13/15)[26,28]. In 
this study, the en bloc and curative resection rates of 
secondary ESD were 92.9% and 89.3%, respectively, 
which were comparable with those reported previously 
for secondary ESD. Two patients in the early salvage 
ESD group had no residual tumor. Although, they 
showed histological confirmation of positive lateral 
margins of the initial ESD specimen, no residual lesion 
was detected due to burning effects on the tissue by 
electrosurgical unit. 
Early and late salvage ESD, which were both 
performed after histological confirmation of positive 
lateral margins of the primary ESD specimen, did 
not involve en bloc resection of the primary lesion. 
Therefore, the risks of local recurrence and lymph 
node metastasis resulting from piecemeal resection 
were always taken into consideration. Hence, careful 
surveillance after early and late salvage ESD is also very 
important. In this study, there was no local recurrence 
during the mean follow-up period in any patient who 
received secondary ESD. 
There is no consensus on the timing of salvage 
ESD. Until now, there were few reports about the 
feasibility and effectiveness of early salvage ESD[6,26,31]. 
In this study, we compared the clinicopathologic factors 
between early salvage ESD and late salvage ESD 
and found no significant differences in procedure or 
oncologic outcomes. However, further study about the 
timing of salvage ESD will be needed.
Although this study was retrospective with a small 
number of patients, this is the first study to report the 
feasibility and safety of secondary ESD according to the 
timing of ESD. 
In conclusion, we found that secondary ESD appears 
to be a feasible and curative treatment. When we 
consider the morbidity of gastrectomy, secondary ESD 
of residual or locally recurrent gastric neoplasms is a 
good therapeutic option worth pursuing, although the 




Endoscopic submucosal dissection (ESD) is an accepted curative treatment 
option for gastric tumors with very low local recurrence. However, residual or 
locally recurrent tumors occur rarely after ESD. Although secondary ESD is 
technically demanding, it can be applied to residual or recurrent tumors with 
scar and dense fibrotic submucosa. We investigated the feasibility and safety 
of secondary ESD for gastric tumors. We also categorized secondary ESD into 
three groups according to the surgical strategy (early salvage, late salvage, or 
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late secondary ESD) and analyzed them. 
Research motivation
There is no consensus on the timing of salvage ESD. Until now, there were few 
reports about the feasibility and effectiveness of early salvage ESD.
Research objectives
To investigate the feasibility and safety of secondary ESD for residual or locally 
recurrent gastric tumors. 
Research methods
Between 2010 and 2017, 1623 consecutive patients underwent ESD for 
gastric neoplasms at a single tertiary referral center. Among these, 28 patients 
underwent secondary ESD for a residual or locally recurrent tumor. Our analysis 
compared clinicopathologic factors between primary ESD and secondary ESD 
groups. 
Research results
The en bloc resection and curative rate of resection of secondary ESD were 
92.9% and 89.3%. The average procedure time of secondary ESD was 
significantly longer than primary ESD, and the adverse events rate was not 
statistically different but trended slightly higher in the secondary ESD group 
compared to the primary ESD group. Patients who received secondary ESD 
had favorable outcomes without severe adverse events. During a mean follow-
up period, no local recurrence occurred in patients who received secondary 
ESD. 
Research conclusions
Although it requires greater technical efficiency and longer procedure time, 
secondary ESD of residual or locally recurrent gastric tumors appears to be 
feasible and curative treatment.
Research perspectives
Secondary ESD of residual or locally recurrent gastric tumors is a feasible and 
curative treatment.
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